HC Wainwright Reaffirms Neutral Rating for Checkpoint Therapeutics (NASDAQ:CKPT)
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They currently have a $4.10 price objective on the stock. HC Wainwright’s target price would indicate a potential upside of 3.02% from the stock’s […]
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They currently have a $4.10 price objective on the stock. HC Wainwright’s target price would indicate a potential upside of 3.02% from the stock’s […]
